최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기大韓韓醫學方劑學會誌 = Herbal formula science, v.30 no.3, 2022년, pp.123 - 135
장윤재 (원광대학교 한의과대학 생리학교실) , 김혜윰 (원광대학교 한의과대학 생리학교실) , 홍미현 (원광대학교 한의과대학 생리학교실) , 윤정주 (원광대학교 한의과대학 생리학교실) , 이호섭 (원광대학교 한의과대학 생리학교실) , 강대길 (원광대학교 한의과대학 생리학교실)
Oryeongsan (ORS), a formula composed of five herbal medicines, has long been used to treat impairments of the regulation of body fluid homeostasis. The purpose of this study was to determine the antihypertensive and renal protective effects of ORS in rats with hypertension. Spontaneously hypertensiv...
Katholi RE, Couri DM. Left ventricular hypertrophy: Major risk factor in patients with hypertension: Update and practical clinical applications. Int. J. Hypertens. 2011;495349.
Mancia G, Omboni S, Parati G. The importance of blood pressure variability in hypertension. Blood Press Monit. 2000;5:S9-S15.
Creemers EE. Pinto YM. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc. Res. 2011;89:265-272.
Eriguchi M. Tsuruya K, Haruyama N, Yamada S, Tanaka S, Suehiro T, Noguchi, H, Masutani K, Torisu K, Kitazono T. Renal denervation has blood pressure-independent protective effects on kidney and heart in a rat model of chronic kidney disease. Kidney Int. 2014;87:16-127.
Cho E, Kim M, Ko YS, Lee HY, Song M, Kim HK, Cho WY, Jo SK. Role of inflammation in the pathogenesis of cardiorenal syndrome in a rat myocardial infarction model. Nephrol. Dial. Transplant. 2013;28:2766-2778.
Cardinale JP, Sriramula S, Pariaut R, Guggilam A, Mariappan N, Elks C, Francis J. HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats. Hypertension 2010;56:437-444.
Elks CM, Mariappan N, Haque M, Guggilam A, Majid DS, Francis J. Chronic NF-{kappa}B blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR. Am. J. Physiol. Renal Physiol. 2009;296:F298-F305.
Moubarak M, Jabbour H, Smayra V, Chouery E, Saliba Y, Jebara V, Fares N. Cardiorenal syndrome in hypertensive rats: Microalbuminuria, inflammation and ventricular hypertrophy. Physiol. Res. 2012;61:13-24.
Liu Y, Zhang R, Qu H, Wu J, Li L, Tang Y. Endothelial microparticles activate endothelial cells to facilitate the inflammatory response. Mol. Med. Rep. 2017;15:1291-1296.
Hsueh WA, Quinones MA. Creager MJ, Endothelium in insulin resistance and diabetes. Diabetes Rev. 1997;5:343-52.
S Godo, H Shimokawa. Endothelial Functions. Arterioscler Thromb Vasc Biol. 2017;Sep;37(9):e108-e114.
Busse R, Fleming I. The endothelial organ. Curr Op Cardiol. 1993;8:719-27.
Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27-36.
Gibbons GH, Dzau VJ. Molecular therapy for vascular diseases. Science. 1996;272:689-93.
Reiling N, Kroncke R, Ulmer AJ. Nitric oxide of synthase:expression the endothelial, Ca 2+ /calmodulin-dependent isoform in human B and T lymphocytes. Eur J Immunol. 1996;26:511-6.
Shaul PW, North AJ, Wu LC. Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium. J Clin Invest. 1994;94:2231-6.
Chou TC, Yen MH, Li CY, Ding YA. Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension. 1998;31:643-8.
Ahmad A, Dempsey SK, Daneva Z, Azam M, Li N, PL Li, Ritter JK. Role of Nitric Oxide in the Cardiovascular and Renal Systems. Int J Mol Sci. 2018 Sep 3;19(9):2605.
Waghe P, Sarath TS, Gupta P, Kandasamy K, Choudhury S, Kutty HS, Mishra SK, Sarkar SN. Arsenic causes aortic dysfunction and systemic hypertension in rats: Augmentation of angiotensin II signaling. Chem. Biol. Interact. 2015;237:104-114.
Ichiki T, Usui, M, Kato M, Funakoshi Y, Ito K, Egashira K, Takeshita A. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension 1998;31:342-348.
Flanagan ET, Buckley MM, Aherne CM, Lainis F, Sattar M, Johns EJ. Impact of cardiac hypertrophy on arterial and cardiopulmonary baroreflex control of renal sympathetic nerve activity in anaesthetized rats. Exp. Physiol. 2008;93:1058-1064.
Grossi L. Hydrogen sulfide induces nitric oxide release from nitrite. Bioorg. Med. Chem. Lett. 2009;19:6092-6094.
JY Kang, KW Kang, MJ Jeong, HJ Kim, IS Jang, A Survey of Hypertension Treatment in Korean Medicine. The Journal of Internal Korean Medicine. 2016;37(6):1022-1029.
Brouwers S, Sudano I, Kokubo Y, Sulaica EM. Arterial hypertension. Lancet. 2021; Jul 17;398(10296): 249-261.
Liu W, Tang F, Deng Y, Li X, Lan T, Zhang X. Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition. Mol Cell Biochem. 2009;325:99.
He L, Rong X, Jiang J, M Liu, P Q, Li L. Amelioration of anti-cancer agent adriamycin-induced nephritic syndrome in rats by Wulingsan (Gorei-San), a blended traditional Chinese herbal medicine. Food Chem Toxicol. 2008;46:1452.
Katholi RE, Couri DM. Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications. Int J Hypertens. 2011;495349.
Messerli FH, Rimoldi SF, Bangalore S. The transition from hypertension to heart failure: contemporary update. JACC Heart Fail. 2017;5: 543-551.
Pravenec M, Kren V, Landa V, Mlejnek P, Musilova A, Silhavy J, Simakova M, Zidek V. Recent progress in the genetics of spontaneously hypertensive rats. Physiol Res. 2014;63(Suppl 1):S1-8.
Hultstrom M. Development of structural kidney damage in spontaneously hypertensive rats. J Hypertens. 2012;Jun:30(6):1087-91.
Pinto YM, Paul M, Ganten D. Lessons from rat models of hypertension:From Goldblatt to genetic engineering. Cardiovasc. Res. 1998;39:77-88.
Okamoto K, Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 1963;27:282-293.
Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 2003;108:560-565.
Conrad CH, Brooks WW, Hayes JA, Sen S, Robinson KG, Bing OH. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation 1995;91: 161-170.
Bing OH, Brooks WW, Robinson KG, Slawsky MT, Hayes JA, Litwin SE, Sen S, Conrad CH. The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J. Mol. Cell. Cardiol. 1995;27:383-396.
Friberg P, Sundelin B, Bohman SO, Bobik A, Nilsson H, Wickman A, Gustafsson H, Petersen J, Adams MA. Renin-angiotensin system in neonatal rats: Induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int. 1994;45:485-492.
Tufro-McReddie A, Romano LM, Harris JM, Ferder L, Gomez RA. Angiotensin II regulates nephrogenesis and renal vascular development. Am. J. Physiol. 1995;269:F110-F115.
Shibasaki Y, Masaki H, Nishiue T, Nishikawa M, Matsubara H, Iwasaka T. Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease. Nephron. 2002;90(3):256-61.
Kim HY, Ahn YM, Na SW, Jang YJ, Kang DG, Lee HS, Cho KW. Oryeongsan (Wulingsan) ameliorates impaired ANP secretion of atria from spontaneously hypertensive rats. Biomed Pharmacother. 2022;146:112433.
Lerman LO, Kurtz TW, Touyz RM, Ellison DH, Chade AR, Crowley SD, Mattson DL, Mullins JJ, Osborn J, Eirin A, Reckelhoff JF, Iadecola C, Coffman TM. Animal Models of Hypertension: A Scientific Statement From the American Heart Association. Hypertension. 2019;73(6):e87-e120
Escudero EM, Hurtado de MCC, Perez NG, Tufare AL. Echocardiographic assessment of left ventricular midwall mechanics in spontaneously hypertensive rats. Eur J Echocardiogr, 2004;5(3);169-175,
Frohlich ED. An updated concept of left ventricular hypertrophy risk in hypertension. Ochsner J. 2009;9:181-190.
Raman SV. The hypertensive heart. J. Am. Coll. Cardiol. 2010;55:91-96.
Devereux RB, Pickering TG, Alderman MH, Chien S, Borer JS. Laragh JH. Left ventricular hypertrophy in hypertension. Prevalence and relationship to pathophysiologic variables. Hypertension 1987;9: 53-60.
Zanchetti A. Cardiac hypertrophy as a target of antihypertensive therapy. Nat Rev Cardiol. 2010;7:66-67.
Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension, 1993;21:391-397.
Mitchell CJ, Churchward-Venne TA, West DW, Burd NA, Breen L, Baker SK, Phillips SM. Resistance exercise load does not determine training-mediated hypertrophic gains in young men. J Appl Physiol, 2012;113:71-77.
Intengan HD, Schiffrin EL. Vascular remodeling in hypertension:Roles of apoptosis, inflammation, and fibrosis. Hypertension 2001;38: 581-587.
Mitchell CJ, Churchward-Venne TA, Parise G, Bellamy L, Baker SK, Smith K, Atherton PJ, Phillips SM. Acute post-exercise myofibrillar protein synthesis is not correlated with resistance training-induced muscle hypertrophy in young men. PLoS ONE, 2014;9:e89431.
Chou TC, Yen MH, Li CY, Ding YA. Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 1998;31:643-648.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.